Sterically stabilized liposomes containing gentamicin: limitations to gentamicin encapsulation

被引:5
作者
Ruijgrok, EJ
Vulto, AG
van Etten, EM
机构
[1] Erasmus Med Ctr Rotterdam, Dept Med Microbiol & Infect Dis, NL-3015 GD Rotterdam, Netherlands
[2] Erasmus Med Ctr Rotterdam Hosp Pharm, NL-3015 GD Rotterdam, Netherlands
关键词
sterically stabilized liposomes; gentamicin;
D O I
10.3109/08982109909024791
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As sterically stabilized liposomes (SSL) containing the aminoglycoside gentamicin prepared by the method of passive loading are characterized by a low drug to lipid ratio, we attempted to prepare gentamicin containing SSL with a more efficient encapsulation. Passive loading of a dried lipid film (PEG-DSPE:PHEPC: cholesterol = 0.15:1.85:1.0) with a solution containing 125 mg gentamicin per 250 mu mole lipid yielded liposomes with an encapsulation efficiency of 4.0 +/- 0.4% and a gentamicin loading of 28.0 +/- 0.7 mu g gentamicin/mu mole lipid. Encapsulation efficiency was calculated as the percentage of gentamicin incorporated into liposomes relative to the initial total amount of gentamicin in solution and gentamicin loading was calculated as the amount of gentamicin incorporated in liposomes relative to the content of total lipid. Active loading of gentamicin into preformed liposomes which exhibit a transmembrane pH gradient resulted in a lower encapsulation efficiency and gentamicin loading (0.4 +/- 0.1% and 4.3 +/- 1.2 mu g/mu mole, respectively). Addition of calcium ions to the hydration buffer did not alter the encapsulation efficiency nor the gentamicin loading in both loading strategies. In conclusion, it seems that the encapsulation efficiency for gentamicin in SSL with the lipid composition PEG-DSPE, PHEPC and cholesterol (in a molar ratio 0.15: 1.85: 1.0) is limited to 4%, or 28 mu g gentamicin per mu mole lipid. The preparation method to achieve this encapsulation is the passive loading of liposomes with gentamicin.
引用
收藏
页码:291 / 300
页数:10
相关论文
共 26 条
[1]   Antibacterial activity of liposomal amikacin against Pseudomonas aeruginosa in vitro [J].
Antos, M ;
Trafny, EA ;
Grzybowski, J .
PHARMACOLOGICAL RESEARCH, 1995, 32 (1-2) :85-87
[2]   ENHANCED LOCALIZATION OF LIPOSOMES WITH PROLONGED BLOOD-CIRCULATION TIME IN INFECTED LUNG-TISSUE [J].
BAKKERWOUDENBERG, IAJM ;
LOKERSE, AF ;
TENKATE, MT ;
STORM, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1138 (04) :318-326
[3]   EFFICACY OF GENTAMICIN OR CEFTAZIDIME ENTRAPPED IN LIPOSOMES WITH PROLONGED BLOOD-CIRCULATION AND ENHANCED LOCALIZATION IN KLEBSIELLA PNEUMONIAE-INFECTED LUNG-TISSUE [J].
BAKKERWOUDENBERG, IAJM ;
TENKATE, MT ;
STEARNECULLEN, LET ;
WOODLE, MC .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :938-947
[4]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[5]  
BARZA M, 1984, INVEST OPHTH VIS SCI, V25, P486
[6]  
BEGG EJ, 1995, BRIT J CLIN PHARMACO, V39, P597
[7]   SUCCESSFUL TREATMENT USING GENTAMICIN LIPOSOMES OF SALMONELLA-DUBLIN INFECTIONS IN MICE [J].
FIERER, J ;
HATLEN, L ;
LIN, JP ;
ESTRELLA, D ;
MIHALKO, P ;
YAUYOUNG, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) :343-348
[8]   GENTAMICIN ALTERS MEMBRANE-STRUCTURE AS SHOWN BY FREEZE-FRACTURE OF LIPOSOMES [J].
FORGE, A ;
ZAJIC, G ;
DAVIES, S ;
WEINER, N ;
SCHACHT, J .
HEARING RESEARCH, 1989, 37 (02) :129-139
[9]   THERAPY OF MYCOBACTERIUM-AVIUM COMPLEX INFECTIONS IN BEIGE MICE WITH STREPTOMYCIN ENCAPSULATED IN STERICALLY STABILIZED LIPOSOMES [J].
GANGADHARAM, PRJ ;
ASHTEKAR, DR ;
FLASHER, DL ;
DUZGUNES, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) :725-730
[10]   TRANSMEMBRANE AMMONIUM-SULFATE GRADIENTS IN LIPOSOMES PRODUCE EFFICIENT AND STABLE ENTRAPMENT OF AMPHIPATHIC WEAK BASES [J].
HARAN, G ;
COHEN, R ;
BAR, LK ;
BARENHOLZ, Y .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1151 (02) :201-215